Pharma Equity Group A/S (CPH:PEG)
Denmark
· Delayed Price · Currency is DKK 0.0888
-0.0002 (-0.22%)
Apr 28, 2026, 3:19 PM CET
Pharma Equity Group Market Cap
Pharma Equity Group has a market cap or net worth of 109.25 million as of April 28, 2026. Its market cap has decreased by -35.51% in one year.
Market Cap
109.25M
Enterprise Value
116.81M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since March 27, 2023, Pharma Equity Group's market cap has decreased from 767.22M to 109.25M, a decrease of -85.76%. That is a compound annual growth rate of -46.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 109.25M | -4.71% |
| Dec 30, 2025 | 114.65M | -50.84% |
| Dec 30, 2024 | 233.24M | -46.98% |
| Dec 29, 2023 | 439.87M | -42.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,153.29B |
| Genmab | 105.04B |
| Coloplast | 93.02B |
| ALK-Abelló | 50.03B |
| Gubra | 5.22B |
| BioPorto | 481.25M |
| ViroGates | 102.10M |
| Scandinavian Medical Solutions | 82.31M |